Surveillance, Epidemiology, and End Results Program

MP/H Rules/Histology--Bladder:  Is urothelial carcinoma, high-grade, predominantly solid type, coded as 8120/3 or 8230/3? See Discussion.

Reportability--Liver:  Is intraductal papillary mucinous neoplasm (IPMN) of the liver a reportable diagnosis? See Discussion.

First course of treatment/Other therapy--How do you code medical marijuana when given as "treatment?"  See Discussion.

MP/H Rules/Histology--Pancreas:  What is the histology code of invasive adenocarcinoma, non-mucinous with intraductal tubulopapillary features, moderately differentiated, from the pathology report final diagnosis of the pancreas?  Does 'intraductal" refer to a non-invasive/in-situ component or describe the pattern of growth?

MP/H Rules/Multiple primaries--Bladder: Is recurrence of bladder cancer the same primary if the patient has had multiple recurrences each within 3 years of recurrences but 3 years has passed since initial diagnosis date?

MP/H Rules, Multiple Primaries--Heme and Lymphoid Neoplasms:  Does Rule M3 at (single primary) or Rule M13 (multiple primaries) apply in a case with chronic myelomonocytic leukemia seen in the blood and biopsy and granulocytic sarcomas identified in skin biopsies?  See Discussion.

MP/H Rules/Histology--Brain and CNS: What is the histology code for a patient with a pathology report Final Diagnosis indicating, mucin-rich neuroepithelial neoplasm, favor low-grade? See Discussion.

Reportability--Brain and CNS: Is meningioangiomatosis reportable as meningiomatosis (9530/1) or angiomatous meningioma (9534/0)?  See Discussion.

Histology--Sarcoma:  What is the histology code for epithelioid angiosarcoma?

Reportability--Ovary:  Is ovarian mucinous borderline tumor of intestinal type with microinvasion reportable? If reportable, what is the histology? See Discussion.